Cystiprost

Dietary supplement.
It is a valid support towards the functional protection of the prostate and bladder.
Lapacho (Tabebuia Avellanedae)
The middle part of the bark is used for this plant to treat various ailments. The antiseptic activity of the Lapacho extract (Tabebuia Avellanedae) and its 18 components has shown inhibitory properties towards gram-positive bacteria (staphylococci, streptococci), and also towards gram-negative (brucella) and fungi (candida albicans). The active ingredients of Lapacho (Tab. Av.) Interfere in the energy and enzymatic production of pathogenic microorganisms and viruses, causing their death. It has also been found that "lapachol" and the other components (quinones, naphthoquinones and anthraquinones) are able to exert immunostimulating effects on granulocytes, macrophages and lymphocytes. Furthermore, Lapacho exerts an antioxidant effect through “carnasol”, one of its most active constituents, which inhibits free radicals and inflammatory leukotrienes. As reported, Lapacho (Tab. Av.) Is of particular utility and help in the treatment of acute ecronic prostatitis and benign prostatic hypertrophy.
"Crystals" lycopene
Carotenoid present particularly in tomatoes and in various species of berries, vegetables and mushrooms, is one of the most powerful antioxidants reducing the risk of chronic inflammation of the prostate. Accumulating, as well as in the prostate, in the adrenal glands, in the testicles, in the liver, it acts against cell proliferation and aging, which are possible causes of many diseases. Characteristic of considerable importance is given by the type of Lycopene used in the Cystiprost. It derives from absolutely vegetable extraction, coming from a fungus (Blakeslea Trispora), a method protected by a world patent, which guarantees feasibility for over 24 months, bioavailability, dissolution in cold water (CWD) and comfortable storage mode.
MSM (methylsufonylmethane)
It occurs naturally in animal and plant organisms and in the human body, particularly in the blood and urine. MSM has a strong pain relieving power as well as a diuretic, antibacterial and antioxidant activity. An important feature is the total absence of toxicity. It also improves dysuria by reducing muscle spasm.
Curcumin
Extracted from the rhizome of Curcuma longa, it has an anti-inflammatory action, comparable if not superior to cortisone, inhibiting the production of cytokines (molecules that trigger inflammatory processes at the cellular level).
Cranberry
Traditionally used for urinary tract and bladder infections. Randomized, controlled clinical studies support its use specifically as a preventive agent in individuals predisposed to recurrent bladder infections and urinary tract infections in general. Cranberry acts as a urine acidifier due to its hippuric acid content, but the currently most recognized and accredited activity is due to the presence of proanthocyanidins, which inhibit the adhesion of type P fimbriae of the uropathogenic strains of EscherichiaColi, an activity enhanced by vitamin C , present in Cistiprost, which leads to an enhancement of intravesical acidosis by increasing its antibacterial defenses. The content of Cranberry rich in flavonoids and phenolic acids limits the oxidative and inflammatory processes affecting the vascular endothelium suggesting that these compounds could reduce angiogenesis.
C vitamin
It acts as an antioxidant, fights bacterial infections, favors the use of energy at the cellular level, promotes the synthesis of norepinephrine, promotes fat burning, neutralizes toxic substances by promoting elimination and protects the cell membrane from the destructive action of free radicals .
Cistiprost, with a combined and synergistic action of itsspecific components, covered by a patent, intervenes on the antiprostatic, anti-inflammatory, immune, anti-free radicals and anti-tumor prevention activities. It also appears to be an adjuvant towards irritative and inflammatory stages of the bladder.

Ingrediants
One tablet contains:
lapacho; lycopene crystals; microcrystalline cellulose; curcumin; cranberry; C vitamin.

How to use
Take 1-2 tablets per day, according to medical opinion, preferably at least one hour before meals.

Warnings
Do not exceed the recommended daily dose.
Keep out of the reach of children under 3 years of age.
Supplements are not intended as a substitute for a varied diet.
For pregnant or lactating women and children it is recommended to consult the doctor's opinion.

Format
Pack of 20 tablets.

Cod. EUPH0022.

Bibliography
- Matthias Oelke, Martin C. Michel, What do we really know aboutbenign prostatic hyperplasia and lower urinary tract symptoms in adult men? HannoverMedical School, Germany and University of Amsterdam, World J Urol (2011) 29: 141–142DOI 10.1007 / s00345-011-0664-5.
- Yallapu MM, Jaggi M, Chauhan SC., Beta-Cyclodextrin-curcuminself-assembly enhances curcumin delivery in prostate cancer cells. USA. Colloids Surf BBiointerfaces. 2010 Aug 1; 79 (1): 113-25. Epub 2010 Apr 3.
- Marie-Hélène Teiten, François Gaascht, Serge Eifes, Mario Dicato, Marc Diederich, Chemopreventive potential of curcumin inprostate cancer. Luxembourg, Luxembourg Genes Nutr (2010) 5: 61–74 DOI10.1007 / s12263-009-0152-3.
- N Krzysztof Waliszewski, DSC, Blasco Gabriela, MSc, Nutraceutical properties of lycopene. Mexico Salud Publica Mex vol. 52 n. 3Cuernavaca May / June 2010.
- Moon DO, Kang CH, Kim MO, Jeon YJ, Lee JD, Choi YH, Kim GY Beta-lapachone (LAPA) decreases cell viability and telomerase activity in leukemia cells: suppression of telomerase activity by LAPA. Republic of Korea. J Med Food. 2010 Jun; 13 (3): 481-8.
- Daniella Bianchi-Frias, Funda Vakar-Lopez, Ilsa M. Coleman, Stephen R. Plymate, May J. Reed, Peter S. Nelson, The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment. Washington, September 1,2010.
- GUO Li-jun, TANG Yuan, GUO Chao-ming and ZHANG Xiang-hua, Impact of primary hypertension on hematuria of the patients with benign prostatichyperplasia. Peking University, Gansu Province People Hospital, Lanzhou, Chin Med J 2010; 123 (9): 1154- 1157.
- Camila B. Piantino, Fernanda A. Salvadori, Pedro P. Ayres, Raphael B. Kato, Victor Srougi, Katia R. Leite, Miguel Srougi, An Evaluation of the Anti-neoplastic Activity of Curcumin in Prostate Cancer Cell Lines. Laboratory of Medical Investigation (CBP, FAS, PPA, RBK, VS, KRL, MS), Sao Paulo, Brazil International Braz JUrol Vol. 35 (3): 354-361, May - June, 2009.
- Lívia L. Corrêa1, Giovanna A. Balarini Lima, Helena B. de Melo Paiva, Cíntia M. dos Santos Silva, Suzana A. Cavallieri, LuizCarlos D. de Miranda, Mônica R. Gadelha, Prostate cancer and acromegaly. Brasil ArqBras Endocrinol Metab. 2009; 53 (8): 963-8.
- Marion ET McMurdo1, Ishbel Argo, Gabby Phillips, Fergus Dalyand Peter Davey, Cranberry or trimethoprim for the prevention of recurrent urinary tractinfections? A randomized controlled trial in older women. School, University of Dundee, Scotland, UK Journal of Antimicrobial Chemotherapy (2009) 63, 389–395.
- Wertz K., Lycopene effects contributing to prostate health. DSMNutritional Products Ltd., Basel, Switzerland Nutr Cancer 2009 Nov; 61 (6): 775-83.
- Chan R, Lok K, Woo J., Prostate cancer and vegetableconsumption. Mol Nutr Food Res. 2009 Feb; 53 (2): 201-16.
- Andrzejewski T, Deeb D, Gao X, Danyluk A, Arbab AS, DulchavskySA, Gautam SC., Therapeutic efficacy of curcumin / TRAIL combination regimen forhormone-refractory prostate cancer. Department of Surgery, Detroit, MI, USA. Oncol Res. 2008; 17 (6): 257-67.
- Eyong KO, Kumar PS, Kuete V, Folefoc GN, Nkengfack EA, BaskaranS., Semisynthesis and antitumoral activity of 2-acetylfuranonaphthoquinone and othernaphthoquinone derivatives from lapachol. Indian Institute of Technology Madras, India Bioorg Med Chem Lett. 2008 Oct 15; 18 (20): 5387-90. Epub 2008 Sep 17.
- Lien YC, Kung HN, Lu KS, Jeng CJ, Chau YP., Involvement ofendoplasmic reticulum stress and activation of MAP kinases in beta-lapachone-inducedhuman prostate cancer cell apoptosis. Taiwan. Histol Histopathol. 2008 Nov; 23 (11): 1299-308.
- Thore Santel, Gabi Pflug, Nasr YA Hemdan, et all., CurcuminInhibits Glyoxalase 1-A Possible Link to Its Anti-Inflammatory and Anti-Tumor Activity.Institute of Biochemistry, Germany Daniel Tome October 23, 2008.
Jepson RG, Craig JC., Cranberries for preventing urinary tract infections. Cancer CareResearch Center Stirling, UK Cochrane Database Syst Rev. 2008 Jan 23 (1): CD001321.
- Ke-Hung Tsui et al., Curcumin Blocks the Activation of Androgen and Interlukin-6 on Prostate-Specific Antigen Expression in Human Prostatic CarcinomaCells. Department of Urology and the Molecular Image Center Taiwan, Republic of ChinaJepson RG, Craig JC. , A systematic review of the evidence for cranberries andblueberries in UTI prevention. University of Stirling, UK Mol Nutr Food Res. 2007 Jun; 51 (6): 738-45.
- Catherine C., Neto Cranberry and Its Phytochemicals: A Review of In Vitro Anticancer Studies. University of Massachusetts – Dartmouth J. Nutr. 137: 186S – 193S, 2007.
- Salman H, Bergman M, Djaldetti M, Bessler H., Lycopene affectsproliferation and apoptosis of four malignant cell lines. Tel-Aviv University, Ramat-Aviv, Israel. Biomed Pharmacother. 2007 Jul; 61 (6): 366-9. Epub 2007 Mar 19.
- Sharmila Shankar and Rakesh K. Srivastava, Involvement of Bcl-2family members, phosphatidylinositol 3-kinase / AKT and mitochondrial p53 in curcumin (diferulolylmethane) - induced apoptosis in prostate cancer. University of texas HealthCenter, Tyler International Journal of Oncology 30: 905-918, 2007.
- Kim SO, Kwon JI, Jeong YK, Kim ND, Choi YH, Lapacho tree (Tabebuia avallanedae) anti-inflammatory and anti-cancer activities. Dongeui University College of Oriental Medicine. Biosci Biochem. 2007 Sep; 71 (9): 2196-76 2007 Sep. 7.
- Liu Y, Black MA, Caron L, Camesano TA., Role of cranberry juiceon molecular-scale surface characteristics and adhesion behavior of Escherichia coli. Worcester Polytechnic Institute Biotechnol Bioeng. 2006 Feb 5; 93 (2): 297-305.
- Edward H. Oswald, Descriptive, analytical and activity report of the “Lapacho-Tabebuia”. From British Journal of Phytotherapy, vol. 3 n. 3, 1993/1994.
- Ammon HP, Safayhi H, Mack T, Sabieraj J., Mechanism ofantiinflammatory actions of curcumine and boswellic acids. Department of Pharmacology, Tübingen, FRG. J Ethnopharmacol. 1993 Mar; 38 (2-3): 113-9.
- Oga S. and Sekino T, Toxicidade and anti-inflamatory atividade of Tabebuia Avell. Lorentz and Griesbach. Rev Fac Farm Bioquim S. Paulo 7, 47-53, 1969.